在2型生物治疗时,严重的异酸性喘的纵向多轨迹表型
Duong Duc Pham1, Ji-Hyang Lee1, Hyouk-Soo Kwon1
1Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
The World Allergy Organization journal
|December 6, 2024
概括
了解严重乙酸性喘 (SEA) 患者在生物药物上的发展轨迹是关键. 纵向生物标志物分析揭示了不同的患者表型,并告知了最佳的治疗监测,以获得更好的结果.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在2型生物药物治疗中,严重酸性喘 (SEA) 患者的进展仍然不太清楚.
- 识别不同的纵向表型对于优化治疗策略至关重要.
研究的目的:
- 探索SEA患者的独特纵向表型,这些患者接受了不同类型2生物制剂的治疗.
- 确定关键的喘生物标志物,预测治疗反应和疾病进展.
主要方法:
- 分析了101名成人SEA患者,分为抗IL5/IL5Rα (n=51) 和抗IL-4Rα (n=50) 抗体治疗组.
- 应用多轨迹分析对1秒内强制呼气体积 (FEV1),血中乙素计数 (BEC) 和12个月内部分呼出的氧化 (FeNO) 进行了分析.
- 研究了确定轨迹集群和临床参数之间的关联.
主要成果:
- 抗IL5/IL5Rα组:出现了两个群体;一个基线BEC较高,FEV1较低的群体显示FEV1改善和BEC降低.
- 抗IL-4Rα组:确定了三个群;中度的基线BEC/FeNO预测了更好的FEV1改善和FeNO减少.
- 相反,在基线极低的FeNO和高的BEC表明FeNO增加和FEV1.1减少的进展较差.
结论:
- 整合纵向生物标记数据 (FEV1,BEC,FeNO) 对于最佳监测SEA患者治疗反应至关重要.
- 确定了不同的患者轨迹,可以指导个性化治疗调整,改善临床结果.
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
01:19Antiasthma Drugs: Leukotriene Modifiers
243
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
243
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:20Asthma: Pathogenesis and Management
350
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
350
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
233
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
233